IMAGYNE PLATFORM TECHNOLOGY

AGY Therapeutics, Inc.

Application Filed: 2001-11-30

Trademark Application Details

Mark For: IMAGYNE PLATFORM TECHNOLOGY® trademark registration is intended to cover the category of product research and development directed to delineating cellular signaling pathways underlying the pathological progression of disease. [all]

Status

2022-08-09 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	76344090
Registration Number	2692522
Mark Literal Elements	IMAGYNE PLATFORM TECHNOLOGY
Mark Drawing Type	5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM
Mark Type	SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	SCANNING ON DEMAND 2008-06-13
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	042 - Primary Class (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Attorney Name	David M. Quinlan
Attorney Docket Number	6900.102
Law Office Assigned	L30
Employee Name	CROSS, TRACY L

Timeline

1999-02-12	Date of First Use
1999-02-12	Date of Use In Commerce
2001-11-30	Application Filed
2002-12-10	Published
2002-12-10	Published for Opposition
2003-03-04	Trademark Registered
2008-06-13	Location: SCANNING ON DEMAND
2009-10-10	Cancelled
2009-10-10	Status: Dead/Cancelled
2009-10-10	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	AGY Therapeutics, Inc.
Address	290 Utah Avenue South San Francisco, CALIFORNIA UNITED STATES 94080
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application	IMAGE/TIFF	2001-11-30
Drawing	IMAGE/TIFF	2001-11-30
Paper Correspondence Incoming		2002-07-03
Paper Correspondence Incoming		2002-07-03
Response to Office Action		2002-09-30
Registration Certificate		2003-03-04
Registration Certificate	IMAGE/TIFF	2003-03-04
File Jacket		2008-06-09
Specimen		2008-06-09
Unclassified		2008-06-09

Attorney of Record

DAVID M. QUINLAN
DAVID M. QUINLAN,P.C
40 NASSAU STREET
PRINCETON, NJ 08542

Good, Services, and Codes

(CANCELLED)
IC 042. US 100 101. G & S: Product research and development directed to delineating cellular signaling pathways underlying the pathological progression of disease. FIRST USE: 19990212. FIRST USE IN COMMERCE: 19990212

International Codes:	42
U.S. Codes:	100,101

Type Code	Type
D10000	"PLATFORM TECHNOLOGY"

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SEC. 8 (6-YR)	2009-10-10
CASE FILE IN TICRS	2008-06-13
REGISTERED-PRINCIPAL REGISTER	2003-03-04
PUBLISHED FOR OPPOSITION	2002-12-10
NOTICE OF PUBLICATION	2002-11-20
APPROVED FOR PUB - PRINCIPAL REGISTER	2002-10-17
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2002-09-30
CORRESPONDENCE RECEIVED IN LAW OFFICE	2002-09-30
FINAL REFUSAL MAILED	2002-08-07
PAPER RECEIVED	2002-07-03
CORRESPONDENCE RECEIVED IN LAW OFFICE	2002-07-03
NON-FINAL ACTION MAILED	2002-03-21
ASSIGNED TO EXAMINER	2002-03-01	76503
ASSIGNED TO EXAMINER	2002-02-28	73717

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.